mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
0.14 |
0.4 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.25 |
0.4 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |